Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Stalev

Approved

STANDARD

Stalev

Orion Corporation🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: b333ef5eb50b58db
Company: Orion Corporation
Type: Standard

Approval Details

Approval Id: b333ef5eb50b58db
Drug Approval Philippines Name: Stalev
Product Name: Stalev
Registration Number: DRP-8090
Brand Name: Stalev
Generic Name: Levodopa + Carbidopa + Entecapone
Dosage Form: Film-Coated Tablet
Dosage Strength: 50mg/12.5mg/200mg
Manufacturer: Orion Corporation
Trader: Alvogen Emerging Markets Holdings Limited
Importer: DKSH Philippines, Inc.
Company Detail Path: /organization/orion-corporation
Issuance Date: 25 May 2025
Expiry Date: 21 June 2031
Pharmacologic Category: Anti-parkinsonism
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

b333ef5eb50b58db

Type

Standard

Back to Philippines FDA Approvals

Stalev - Philippines FDA Drug Approval Details